We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

6 hedge funds and large institutions have $9.14M invested in Bio-Rad Laboratories Class B in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3,233% more capital inflows, than outflows

Capital inflows: $27.5K | Capital outflows: $826

0% more funds holding

Funds holding: 6 → 6 (0)

0% more ownership

Funds ownership: 0.62% → 0.62% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$27.5K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$826

BIO.B Hedge Fund Activity: Q2 2018 in Review

6 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q2 2018, worth a combined $9.14M — up 15% from $7.92M a quarter earlier.

Fund positioning in BIO.B was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $27.5K. The largest seller was Susquehanna International Group, cutting an estimated $826.

  • 6 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $9.14M of Bio-Rad Laboratories Class B stock for Q2 2018, up 15% quarter-over-quarter.
  • 0 funds opened new Bio-Rad Laboratories Class B positions in Q2 2018 and 0 closed out.
  • The largest Bio-Rad Laboratories Class B buyer in Q2 2018 was UBS Group, an estimated $27.5K added.
  • The largest Bio-Rad Laboratories Class B seller in Q2 2018 was Susquehanna International Group, an estimated $826 sold.

Based on aggregated 13F filings for Q2 2018.